440 related articles for article (PubMed ID: 16029342)
1. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T
Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
[TBL] [Abstract][Full Text] [Related]
2. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
Carneiro JR; Sato EI
J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
[TBL] [Abstract][Full Text] [Related]
3. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy.
Kreuter A; Tomi NS; Weiner SM; Huger M; Altmeyer P; Gambichler T
Br J Dermatol; 2007 Jun; 156(6):1321-7. PubMed ID: 17408395
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study.
Madan V; August PJ; Chalmers RJ
Clin Exp Dermatol; 2010 Jan; 35(1):27-30. PubMed ID: 19549244
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis.
Rahman P; Humphrey-Murto S; Gladman DD; Urowitz MB
J Rheumatol; 1998 Feb; 25(2):243-6. PubMed ID: 9489814
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus.
Islam MN; Hossain M; Haq SA; Alam MN; Ten Klooster PM; Rasker JJ
Int J Rheum Dis; 2012 Feb; 15(1):62-8. PubMed ID: 22324948
[TBL] [Abstract][Full Text] [Related]
8. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
Lyakhovitsky A; Barzilai A; Heyman R; Baum S; Amichai B; Solomon M; Shpiro D; Trau H
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
[TBL] [Abstract][Full Text] [Related]
9. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice.
Domènech E; Mañosa M; Navarro M; Masnou H; Garcia-Planella E; Zabana Y; Cabré E; Gassull MA
J Clin Gastroenterol; 2008 Apr; 42(4):395-9. PubMed ID: 18277899
[TBL] [Abstract][Full Text] [Related]
10. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
Lampropoulos CE; Sangle S; Harrison P; Hughes GR; D'Cruz DP
Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens.
Cuadrado MJ; Karim Y; Sanna G; Smith E; Khamashta MA; Hughes GR
Am J Med; 2005 Mar; 118(3):246-50. PubMed ID: 15745722
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate treatment for sarcoid-associated panuveitis.
Dev S; McCallum RM; Jaffe GJ
Ophthalmology; 1999 Jan; 106(1):111-8. PubMed ID: 9917790
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
Salim A; Tan E; Ilchyshyn A; Berth-Jones J
Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome.
Cortés-Hernández J; Torres-Salido M; Castro-Marrero J; Vilardell-Tarres M; Ordi-Ros J
Br J Dermatol; 2012 Mar; 166(3):616-23. PubMed ID: 21999437
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease.
Fautrel B; Borget C; Rozenberg S; Meyer O; Le Loët X; Masson C; Koeger AC; Kahn MF; Bourgeois P
J Rheumatol; 1999 Feb; 26(2):373-8. PubMed ID: 9972972
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris.
Baum S; Greenberger S; Samuelov L; Solomon M; Lyakhovitsky A; Trau H; Barzilai A
Eur J Dermatol; 2012; 22(1):83-7. PubMed ID: 22266247
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study.
Du-Thanh A; Merlet S; Maillard H; Bernard P; Joly P; Estève E; Richard MA; Pauwels C; Ingen-Housz-Oro S; Guillot B; Dereure O
Br J Dermatol; 2011 Dec; 165(6):1337-43. PubMed ID: 21777222
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.
Ravelli A; Ballardini G; Viola S; Villa I; Ruperto N; Martini A
J Rheumatol; 1998 Mar; 25(3):572-5. PubMed ID: 9517783
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate for the treatment of adult atopic dermatitis.
Goujon C; Bérard F; Dahel K; Guillot I; Hennino A; Nosbaum A; Saad N; Nicolas JF
Eur J Dermatol; 2006; 16(2):155-8. PubMed ID: 16581567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
